Illudent Therapeutics
PrivateLast Round
Series B
Aug 3, 2026
Total Funding Raised
$250,000
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Illudent Therapeutics operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Grant round in December 2025.
Illudent Therapeutics is a biotechnology company that develops precision oncology therapeutic platforms for the treatment of solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Illudent Therapeutics Comparables
Compare Illudent Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BlossomHill Therapeutics | 84% | |
| 858 Therapeutics | 83% | |
| Breakpoint Therapeutics | 79% |
For institutional investors. Book with your work email.
Illudent Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 3, 2026 | ||||
| Grant | Dec 10, 2025 |
For institutional investors. Book with your work email.
Illudent Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Curebound | Grant |
| Ulu Ventures | Seed |
| SeedFolio | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 3, 2026
Completed Series B funding round.
For institutional investors. Book with your work email.
Illudent Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Illudent Therapeutics's valuation, stock price, and market status.
Is Illudent Therapeutics a public or private company?
Illudent Therapeutics is a private company.
What is the current stock price of Illudent Therapeutics?
Illudent Therapeutics is a private company, so its shares have no public market price. Caplight tracks Illudent Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Illudent Therapeutics worth (valuation)?
Valuation information for Illudent Therapeutics is not publicly available.
Can I buy Illudent Therapeutics stock?
Illudent Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Illudent Therapeutics's last funding round?
Illudent Therapeutics's most recent funding round was Series B on August 3, 2026.
Who are the main investors in Illudent Therapeutics?
Key investors in Illudent Therapeutics include Ulu Ventures.
Will Illudent Therapeutics IPO soon?
No public IPO plans have been announced for Illudent Therapeutics.
How can I track Illudent Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Illudent Therapeutics's shares on secondary markets.